Answer
Nov 19, 2025 - 12:05 PM
The bioavailability is approximately 15–33% for levodopa, around 35% for entacapone, and variable for carbidopa. Bioavailability refers to the proportion of the drug that enters circulation and can have an active effect, which is important for dosing effectiveness.
